Ron Moldaver | Investor Relations |
Gilmore O’Neill | Chief Executive Officer |
Michelle Robertson | Chief Financial Officer |
Baisong Mei | Chief Medical Officer |
Samantha Semenkow | Citi |
Dae Gon Ha | Stifel |
Phil Nadeau | Cowen & Company |
Rick Bienkowski | Cantor Fitzgerald |
Jay Olson | Oppenheimer |
Brian Cheng | JP Morgan |
Luca Issi | RBC Capital Markets |
Greg Harrison | Bank of America |
Yanan Zhu | Wells Fargo |
Gena Wang | Barclays |
Rich Law | Credit Suisse |
Liisa Bayko | Evercore ISI |
Good morning and welcome to Editas Medicine’s Fourth Quarter and Full-year 2022 Conference Call. All participants are now in a listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised that this call is being recorded at the Company’s request.
I would now like to turn the call over to Ron Moldaver, Investor Relations for Editas Medicine.